Loading Events

« All Events

  • This event has passed.

Intravenous Immune Globulin (IVIg) – A newly approved therapeutic option for the treatment of adult dermatomyositis

April 5, 2022 @ 2:00 pm - 3:00 pm EDT

Free
Intravenous Immune Globulin (IVIg) - A newly approved therapeutic option for the treatment of adult dermatomyositis

Register to join on Zoom

Intravenous Immune Globulin (IVIg)

A newly approved therapeutic option for the treatment of adult dermatomyositis

with Rohit Aggarwal, MD, MS

Tuesday, April 5, 2022, at 2 PM Eastern Time

(2 PM ET / 1 CT / 12 MT / 11 AM PT)

Webinar Details

Dermatomyositis (DM) is a rare chronic systemic autoimmune disease with a characteristic skin rash and progressive proximal muscle weakness. In this Zoom webinar, you will get an opportunity to learn about Octapharma’s IVIg therapy and the results of the landmark Progress in Dermatomyositis (ProDERM) study. The successful ProDERM Study resulted in the first and only FDA-approved IVIg therapy for DM in adults.

Myositis Support & Understanding and Octapharma USA are proud to co-sponsor this exciting educational program. We look forward to having you join us!

See the full PDF invite here.

About joining this webinar

REGISTRATION IS REQUIRED for this free webinar. Click the Register button above to get started. After registration, you will receive an email containing all of the information you need to join the webinar on the scheduled time and date. Be sure to check your spam and junk folders if you do not see the email.

Rohit Aggarwal, MD, MS

Professor of Medicine,
Medical Director, Arthritis and Autoimmunity Center;
Department of Medicine / Division of Clinical Immunology & Rheumatology
University of Pittsburgh Medical Center

Dr. Aggarwal is a professor of medicine at the University of Pittsburgh and medical director of Arthritis and Autoimmunity Center at University of Pittsburgh Medical Center. He is the co-director of UPMC Myositis Center. His research and clinical areas of interest are clinical and translational research in inflammatory muscle diseases (myositis) and associated interstitial lung disease. He is the past-chair of the medical advisory board of The Myositis Association (TMA) as well as past-chair of the scientific committee of IMACS.

Dr. Aggarwal is an established independent clinical investigator with significant funding from the NIH, foundations and industry, and currently leading several collaborations internationally with other key leaders in the world. He has maintained an extremely high publication record and received national and international recognition of his work. He continues to be a leader in disease criteria and outcomes measures in myositis as well as in clinical trials of novel therapeutic agents for myositis. He is currently the principal investigator or member of the steering committee for several international phase 2/3 clinical trials in the area of myositis and associated ILD. Dr. Aggarwal is also mentoring the future generation of rheumatologists with great success and attracting younger rheumatologists toward myositis research for the advancement of the field. Dr. Aggarwal lectures at various international conferences and promotes patient education through his YouTube channel.

Get help using Zoom

We use Zoom for all webinars and video support, activity, and education sessions.  Zoom is available for free and you can download and install the software on your computer or laptop, or use the free app for your smartphone and tablet. See the help page we have created to assist you in using Zoom.See Zoom Help »

Check out other upcoming support and education sessions

Event starts in . . .

2022/04/05 14:00:00

Tags:

Details

Date:
April 5, 2022
Time:
2:00 pm - 3:00 pm EDT
Cost:
Free
Event Categories:
,
Event Tags:
, , ,
Website:
https://us02web.zoom.us/webinar/register/WN_Re3N_U6AQFWMk0auPFdLOA

Venue

MSU Zoom Video Session
Video session using Zoom + Google Map
View Venue Website

Organizer

Myositis Support and Understanding (MSU)
Email
info@UnderstandingMyositis.org
View Organizer Website

Other

Suggested Audience
Public, welcome ALL

© 2024 Myositis Support and Understanding Association (MSU). All rights reserved. | View our Privacy Policy, Terms, and Non-Discrimination policy. MSU is a charitable organization with 501(c)(3) tax-exempt status. Federal ID #47-4570748.

View COVID-19 resources and updates, and stay tuned to your state, local, and federal health agencies, along with the CDC.

Log in with your credentials

or    

Forgot your details?

Register for Free Membership

Send this to a friend